Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

DNA

Ginkgo Bioworks Holdings, Inc.

Healthcare · USD

Set alert

Price alert · DNA

All alert types
11.21 USD -1.53 -12.01%
As of Oct 30, 2026 Extended hours 11.34 +1.16%
Bid
11.22 × 2,500
Ask
11.24 × 200
10.61 Day range 12.61
5.48 52-week range 14.98
YTD
+34.90%
1 year
-6.66%
Open
12.12
Prev close
12.74
Mkt cap
754.88M
Vol
2.73M
Avg vol
2.19M
EPS
-5.06
P/E
0.00
Div yield
0.00%
More statistics
Low
10.61
High
12.61
Forward P/E
-5.17
Beta
1.79
Short ratio
6.35
Inst. own
73.73%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
8.08
200-d avg
8.32
1y target
7.00

5D chart

Chart tools
Interval
1m5m15m30m
DNA five-day price chart9.6910.811.812.914.0Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-8.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -1.5×
FY 2019: -97.5×FY 2020: -102×FY 2021: -6.2×FY 2022: -1.3×FY 2023: -3.7×FY 2024: -0.9×FY 2025: -1.5×
FY 2019 5y median -1.5× FY 2025
P/S 2.7×
FY 2019: 215×FY 2020: 167×FY 2021: 34.9×FY 2022: 5.9×FY 2023: 13.0×FY 2024: 2.2×FY 2025: 2.7×
FY 2019 5y median 5.9× FY 2025
P/B 0.9×
FY 2019: 23.6×FY 2020: 27.8×FY 2021: 7.3×FY 2022: 1.6×FY 2023: 3.0×FY 2024: 0.7×FY 2025: 0.9×
FY 2019 5y median 1.6× FY 2025
P/FCF -2.6×
FY 2019: -174×FY 2020: -66.2×FY 2021: -35.3×FY 2022: -9.3×FY 2023: -9.8×FY 2024: -1.3×FY 2025: -2.6×
FY 2019 5y median -9.3× FY 2025
EV/EBITDA -2.9×
FY 2019: -105×FY 2020: -115×FY 2021: -5.2×FY 2022: -0.9×FY 2023: -3.1×FY 2024: -0.9×FY 2025: -2.9×
FY 2019 5y median -2.9× FY 2025
EV/Sales 4.3×
FY 2019: 206×FY 2020: 162×FY 2021: 30.0×FY 2022: 4.1×FY 2023: 10.2×FY 2024: 1.8×FY 2025: 4.3×
FY 2019 5y median 4.3× FY 2025
FCF Yield -38.8%
FY 2019: -0.6%FY 2020: -1.5%FY 2021: -2.8%FY 2022: -10.7%FY 2023: -10.3%FY 2024: -75.0%FY 2025: -38.8%
FY 2019 5y median -10.7% FY 2025

Profitability

Gross Margin 81.5%
FY 2019: 100.0%FY 2020: 79.6%FY 2021: 58.7%FY 2022: 57.3%FY 2023: 78.5%FY 2024: 83.0%FY 2025: 81.5%
FY 2019 5y median 78.5% FY 2025
Operating Margin -185.3%
FY 2019: -132.1%FY 2020: -178.8%FY 2021: -582.6%FY 2022: -462.4%FY 2023: -343.8%FY 2024: -246.5%FY 2025: -185.3%
FY 2019 5y median -343.8% FY 2025
Net Margin -183.8%
FY 2019: -220.2%FY 2020: -165.2%FY 2021: -583.1%FY 2022: -440.6%FY 2023: -355.1%FY 2024: -240.9%FY 2025: -183.8%
FY 2019 5y median -355.1% FY 2025
ROE -61.5%
FY 2019: -24.2%FY 2020: -27.4%FY 2021: -121.6%FY 2022: -121.2%FY 2023: -81.4%FY 2024: -76.4%FY 2025: -61.5%
FY 2019 5y median -81.4% FY 2025
ROIC -30.0%
FY 2019: -10.9%FY 2020: -22.7%FY 2021: -94.3%FY 2022: -91.6%FY 2023: -56.9%FY 2024: -43.0%FY 2025: -30.0%
FY 2019 5y median -56.9% FY 2025
ROA -27.9%
FY 2019: -17.1%FY 2020: -18.8%FY 2021: -88.4%FY 2022: -82.9%FY 2023: -53.6%FY 2024: -39.7%FY 2025: -27.9%
FY 2019 5y median -53.6% FY 2025

Growth (YoY)

Revenue -25.1%
FY 2019: 0.0%FY 2020: 41.5%FY 2021: 309.4%FY 2022: 52.2%FY 2023: -47.4%FY 2024: -9.7%FY 2025: -25.1%
FY 2019 FY 2025
Operating Income 43.7%
FY 2019: 0.0%FY 2020: -91.4%FY 2021: -1234.4%FY 2022: -20.8%FY 2023: 60.9%FY 2024: 35.2%FY 2025: 43.7%
FY 2019 FY 2025
EPS (diluted) 46.5%
FY 2019: 0.0%FY 2020: 3.6%FY 2021: -1288.3%FY 2022: 9.6%FY 2023: 63.3%FY 2024: 42.7%FY 2025: 46.5%
FY 2019 FY 2025
Free Cash Flow 53.2%
FY 2019: 0.0%FY 2020: -189.5%FY 2021: -60.3%FY 2022: 1.9%FY 2023: -10.5%FY 2024: -13.6%FY 2025: 53.2%
FY 2019 FY 2025

Financial Health

Current Ratio 4.9×
FY 2019: 12.8×FY 2020: 5.8×FY 2021: 12.8×FY 2022: 8.4×FY 2023: 6.1×FY 2024: 5.6×FY 2025: 4.9×
FY 2019 5y median 6.1× FY 2025
Quick Ratio 4.9×
FY 2019: 12.8×FY 2020: 5.7×FY 2021: 12.8×FY 2022: 8.4×FY 2023: 6.1×FY 2024: 5.6×FY 2025: 4.9×
FY 2019 5y median 6.1× FY 2025
Debt / Equity 0.9×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.7×FY 2025: 0.9×
FY 2019 5y median 0.3× FY 2025
Net Debt / EBITDA -1.1×
FY 2019: 4.5×FY 2020: 3.4×FY 2021: 0.8×FY 2022: 0.4×FY 2023: 0.9×FY 2024: 0.2×FY 2025: -1.1×
FY 2019 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2019: -29.6×FY 2020: -57.5×FY 2021: -771×FY 2022: -20839×FY 2023: -9295×FY 2024: -5955×FY 2025: 0.0×
FY 2019 5y median -5955× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31